GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sundrug Co 9989.T · JPY

Consumer Staples · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

3,908

+4.52%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Sundrug Co

Its shares trade on Tokyo Stock Exchange under the ticker 9989.T. It has been listed since 17 September 1997. In the fiscal year to 31 March 2026, it reported revenue of ¥842.51bn and net income of ¥31.39bn. At that date it held total assets of ¥475.50bn and shareholders' equity of ¥286.00bn.

Sundrug Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Fuchu-Shi, Tokyo-To. The Drug Store segment is primarily engaged in the sale of pharmaceutical products, cosmetic products and sundry goods, among others. The Discount Store segment is primarily engaged in the sale of foodstuffs, household sundry goods, among others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Food & Staples Retailing
Listed since
17 Sept 1997
Employees
5,241

Leadership

Pay as last reported

  • Mr. Naoki TadaChairman, Director, since 2001
  • Mr. Hiroshi SadakataPresident, Chief Executive Officer, Chairman of Subsidiary, Representative Director, since 2008¥165.0m
  • Mr. Koichi UraExecutive Officer, Chief Director of Sales
  • Mr. Yoshinobu KatoExecutive Officer, Director of Administration
  • Mr. Kazuhiro YamauchiExecutive Officer, Chief Director of Product
  • Mr. Yoshimitsu SakaiDirector of Store Development, Director, since 2010
  • Mr. Takashi TadaDirector, since 2017
  • Mr. Masato MatsumotoIndependent Director
  • Ms. Ritsuko SaitoIndependent Director
  • Ms. Tomoko TsujiIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
55
Environment
66
Social
59
Governance
41
Direct emissions (scope 1)
24,916 t
Energy emissions (scope 2)
157,146 t
Value chain emissions (scope 3)
2,433,338 t
Women in the workforce
62.2%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Sundrug Co Ltd has several key strengths that contribute to its success:

Weaknesses

  • Although Sundrug Co Ltd has achieved significant success, it also faces certain weaknesses:

Opportunities

  • Sundrug Co Ltd can seize various opportunities to further enhance its position:

Threats

  • Sundrug Co Ltd should be mindful of the following potential threats:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.